ACTB antibody - western blot | antibody review based on formal publications
 | |
| This is a review about ACTB antibodies, based on 94 published articles using ACTB antibodies in western blot, immunohistochemistry, immunoprecipitation, immunocytochemistry, and other immunological technologies. It is aimed to help Labome/ExactAntigen visitors find the most suited ACTB antibody. |
| all | ChIP assay | immunocytochemistry | immunoprecipitation | western blot |
EMD BiosciencesEMD Biosciences ACTB products | |
| wb | Oncogene Research Products monoclonal anti-beta-actin antibody was used in western blot to detect beta-actin as a load control in mouse hepatocellular carcinoma cell lines 223. to the paper |
| wb | Calbiochem anti-beta-actin antibody was used in western blot to study the functional expression of the interleukin-11 receptor alpha-Chain and evidence of antiapoptotic effects in human colonic epithelial cells. to the paper |
| wb | Oncogene Research Products anti-actin antibody was used in western blot to study the requirement of galectin-3 phosphorylation for its anti-apoptotic function and cell cycle Aarrest. to the paper |
Sigma-AldrichSigma-Aldrich ACTB products | |
| wb | Sigma anti-?-actin antibody was used to perform western blot in order to show that the absence of p53 can result in tumourgenesis in those mesenchymal stem cells lacking p21. to the paper |
| wb | Sigma anti-beta-actin antibody was used to perform western blot in order to show that PLC?2 is an important player in integrin and Fc receptor-mediated neutrophil functions and the neutrophil-mediated effector phase of autoimmune arthritis. to the paper |
| wb | Sigma anti-ß actin antibody was used as loading control when do west blot in order to study the role of green tea polyphenols on brain defects which were induced by overexpression of DYRK1A. to the paper |
| wb | Sigma anti-beta-actin was used as a probe in western blot in order to prove that the loss of full length CtBP1 expression can induce human melanoma. to the paper |
| wb | Sigma anti-?-actin was used to perform western blot in order to study the role of Bcl-x in regulating apoptosis and tumor progression in a mouse model of pancreatic neuroendocrine cancer. to the paper |
| wb | Sigma-Aldrich anti-beta-actin polyclonal antibodies were used in western blot in order to study the role for proepithelin in stimulating the migration, proliferation, and anchorage-independent growth of prostate cancer cells. to the paper |
| wb | Sigma β-actin was used for reagent in order to study the mechanism of Gfi-1 repressing CDKN2B and encoding p15INK4B through interaction with Miz-1. to the paper |
| wb | Sigma goat anti-?-actin antibody was used for the Western blot in order to show that neutrophils traverse human dermal microvascular endothelial cells using one of two pathways: a transcellular route directly through the cell or a paracellular route through cellular junctions. to the paper |
| wb | Sigma anti-??-actin Ab was used to detect actin in western blot in order to find out the novel mechanism by which eIF4E levels are regulated at the level of mRNA stability. to the paper |
| wb | Sigma Anti-?-actin (AC-15) antibodies were used to do immunoblot analysis in order to demonstrate that valproate attenuates could accelerate atherosclerosis in hyperglycemic ApoE-deficient mice. to the paper |
| ip, wb | Sigma anti-??-Actin was used to detect ??-Actin in immunoprecipitation in order to show that the expression of COMMD1 is regulated while COMMD1 and XIAP interact with each other via some critical residues. to the paper |
| wb | Sigma(AC-72) mouse anti-β-actin was used for Western blot analysis in order to investigate the cooperative oncogenic events between aberrant Rheb-mediated mTORC1 activation and Pten haploinsufficiency. to the paper |
| wb | Sigma anti-beta actin antibody was used in western blot to study the role for human AQP5 in the progression of chronic myelogenous leukemia. to the paper |
| wb | Sigma-Aldrich β-actin antibody was used to address the mechanism of combination UCDA/dexamethasone treatment induced p300-related interactions between HNF1 and glucocorticoid receptor on the AE2 alternate promoter. to the paper |
| wb | Sigma anti-beta-actin antibody was used in western blot to study the relation between overexpression of ribosomal protein L15 and cell proliferation in gastric cancer. to the paper |
| wb | Sigma mouse monoclonal anti-beta-actin antibody was used in western blot to detect beta-actin as a loading control in the human astrocytoma cell line 1321N1. to the paper |
| wb | Sigma anti-beta-actin antibody was used in western blot to detect beta-actin as a loading control in TAK1+/+ and TAK1-/- MEFs and HeLa S3 cells. to the paper |
| wb | Sigma anti-beta-actin antibody was used in western blot to detect beta-actin as a loading control in NCI-H460 and NCI-H1299 cells. to the paper |
| wb | Sigma-Aldrich anti-beta-actin antibody was used in western blot to study the augment of kinase activity by Parkinson's disease-associated mutations in leucine-rich repeat kinase 2. to the paper |
| wb | Sigma anti-beta-actin antibody was used in western blot to study that tyrosine phosphorylation of Sam68 by breast tumor kinase regulates intranuclear localization and cell cycle progression. to the paper |
| wb | Sigma-Aldrich anti-actin antibody was used in western blot to detect actin as a loading control in murine bone marrow cells treated with M-CSF or TRANCE. to the paper |
| wb | Sigma mouse anti-beta-actin monoclonal antibody was used in western blot to study the iron accumulation in human embryonic kidney 293 cells through the interaction of hemojuvelin with neogenin. to the paper |
| wb | Sigma beta-actin antibody was used in western blot as a control to investigate the interactin among Akt, mTOR, and AMPK. to the paper |
| ic, wb | Sigma beta-actin was used in Western blot as a control. to the paper |
| wb | Sigma-Aldrich mouse monoclonal anti-beta-actin antibody was used in western blot to study the overexpression of beta1-chain-containing laminins in capillary basement membranes of human breast cancer and its metastases. to the paper |
| wb | Sigma monoclonal antibody to beta-actin was used in Western blot as a control in the study to investigate the effect of von Hippel Lindau tumor suppressor on iron homeostasis in renal carcinoma cells. to the paper |
| wb | Sigma rabbit polyclonal anti-beta-actin antibody was used in Western blot to investigate PR3-mediated p21 cleavage. to the paper |
| ip, wb | Sigma anti-b-actin antibody was used to investigate the activation of Erk1/2 by intracellular M. leprae. to the paper |
| wb | Sigma antiactin antibody (AC-15) was used in western blot to investigate the regulation of ER alpha proteolysis and transcription. to the paper |
| wb | Sigma anti-beta-actin monoclonal antibody was used in western blot to study the CDX1 as an important molecular mediator of Barrett's metaplasia. to the paper |
| wb | Sigma mouse monoclonal anti-beta-actin antibody was used in western blot to detect beta-actin in rat A7r5 aortic smooth muscle cells. to the paper |
| wb | Sigma antibody which recognizes beta-actin was used in western blot to study that p400 is required for E1A to promote apoptosis. to the paper |
| wb | Sigma anti-actin antibody was used in western blot to study BRCA2 gene expression in human breast cells. to the paper |
| wb | Sigma anti- -actin antibody was used in western blot to study the functional link between FGFR2 signaling and Cbl-mediated alpha-5-integrin expression resulting in altered cell attachment and apoptosis in osteoblasts. to the paper |
| ip, wb | Sigma anti-β-actin antibody was used in western blot and immunoprecipitations to study Amino-terminal domain of ATRIP contributes to intranuclear relocation of the ATR-ATRIP complex following DNA damage. to the paper |
| wb | Sigma anti-beta-actin antibody was used in western blot to study that myristoylated alanine-rich C kinase substrate-mediated neurotensin release via protein kinase C-delta downstream of the Rho/ROK pathway. to the paper |
| wb | Sigma rabbit anti-actin polyclonal antibody was used in western blot to study Cu/Zn-superoxide dismutase (SOD1) mutant-induced motoneuronal cell death. to the paper |
| wb | Sigma-Aldrich anti-beta-actin antibody was used in western blot to study that Cdc42 and RhoB activation are required for mannose receptor-mediated phagocytosis by human alveolar macrophages. to the paper |
| wb | Sigma anti-beta-actin monoclonal antibody was used in western blot to study the characterization of microtubule-associated protein 1S which is a short and ubiquitously expressed member of the microtubule-associated protein 1 family. to the paper |
| ip, wb | Sigma anti-β-actin antibody was used in western blot and immunoprecipitations to study the role of amino-terminal domain of ATRIP intranuclear relocation of the ATR-ATRIP complex following DNA damage. to the paper |
| wb | Sigma anti-beta-actin antibody was used in western blot to study the heterogeneous nuclear ribonucleoprotein A1 as a novel internal ribosome entry site trans-acting factor which modulates alternative initiation of translation of the fibroblast growth factor 2 mRNA. to the paper |
| wb | Sigma-Aldrich antibody to monoclonal antibody to -actin (AC-15) was used in western blot as a loading control to study the presence of RECQL4 in both nucleus and cytoplasm of HeLa cells. to the paper |
| wb | Sigma anti-beta-actin antibody was used in western blot to detect beta-actin as a loading control in human coronary artery endothelial cells (HCAEC) treated with VEGF. to the paper |
| wb | Sigma anti-actin antibody was used in western blot to detect actin as a loading control in B-lymphoid precursor cell line, Reh. to the paper |
| wb | Sigma anti-beta-actin antibody was used in western blot to study the overexpression of mitogen-activated protein kinase phosphatase-1 which is an independent predictor of outcome in patients in non-small cell lung cancer. to the paper |
| wb | Sigma mouse anti-beta-actin antibody was used in western blot to detect beta-actin as loading controls in hepatocytes from livers of fasted and refed control and hGK-KO mice infected with adenovirus human SREBP-1 or adenovirus null. to the paper |
| wb | Sigma-Aldrich monoclonal anti-beta-actin antibody was used in western blot to detect beta-actin as a loading control in splenic B lymphocytes from p85-deficient mice and the corresponding wild-type mice. to the paper |
| wb | Sigma-Aldrich anti-beta-actin antibody was used in western blot to detect beta-actin as a protein loading control in wild-type Jurkat and Jurkat cells stably transfected with Bcl-xL, Bcl-2 or vector control cells. to the paper |
| wb | Sigma monoclonal anti-actin antibody was used in western blot to detect actin as a loading control in Hela, wild-type H2AX (H2AXflox/flox) and H2AX-deficient ES cells irradiated with UV. to the paper |
| wb | Sigma rabbit anti-actin antibody was used in western blot as control to study TOGp (human homolog of XMAP215/Dis1) is required for centrosome integrity, spindle pole organization and bipolar spindle assembly. to the paper |
| wb | Sigma Chemical anti-actin antibody was used in western blot to detect actin as a loading control in U937 cells incubated for 24 h with 1-mM SB or 2- M SAHA. to the paper |
| wb | Sigma anti-actin antibody was used in western blot to detect actin as a load control in U373 cells with human MEKK3 stable transfection and eight ovarian tumors. to the paper |
| wb | Sigma monoclonal anti-beta-actin antibody was used in western blot to detect beta-actin as a load control in fibroblasts containing wild type Cas, CasY253F, or Cas118423. to the paper |
| wb | Sigma-Aldrich mouse monoclonal anti-beta-actin antibody was used in western blot to detect beta-actin as a load control in cortical astrocyte-neuron cocultures from fetal Swiss-Webster mice. to the paper |
| wb | Sigma anti-beta-actin antibody was used in western blot to study the phosphatase MKP1 as a transcriptional target of p53 involved in cell cycle regulation. to the paper |
| wb | Sigma monoclonal anti-beta-actin antibody was used in western blot to study the evidence for a positive role of SHIP in the BCR-ABL- mediated transformation of primitive murine hematopoietic cells and in human chronic myeloid leukemia. to the paper |
| ic, wb | Sigma anti-actin antibody was used in western blot to detect actin as a control of the level of protein expression in BdGBM and in BeGBM cells. to the paper |
| wb | Sigma monoclonal anti-beta-actin antibody was used in western blot to detect beta-actin as a loading control in HeLa cells transfected with Luc siRNA or NudC siRNA. to the paper |
| wb | Sigma monoclonal anti-beta-actin antibody was used in western blot to study that overexpression of copper/zinc superoxide dismutase in transgenic mice protects against neuronal cell death after transient focal ischemia by blocking activation of the Bad cell death signaling pathway. to the paper |
| wb | Sigma Chemical anti-actin antibody was used in western blot to detect actin as a loading control in fibroblast and SWS surgical brain samples. to the paper |
| wb | Sigma anti-beta-actin antibody was used in western blot to study the expression of hypertonicity-induced aquaporin-1 (AQP1) which is mediated by the activation of MAPK pathways and hypertonicity-responsive element in the AQP1 gene. to the paper |
| wb | Sigma-Aldrich anti-actin antibody was used in western blot to detect actin as a loading control in migrating T cells from patient and control. to the paper |
| wb | Sigma monoclonal antibody which recognizes actin was used in western blot as control to study DNA methylation down-regulates CDX1 gene expression in Colorectal Cancer Cell Lines. to the paper |
| wb | Sigma-Aldrich anti-beta-actin monoclonal antibody was used in western blot to detect beta-actin as a loading control in mouse collagen-adherent FN-/- cells. to the paper |
| wb | Sigma mouse monoclonal beta-actin antibody (clone AC15) was used in western blot to study the recruitment of the mitochondrial-dependent apoptotic pathway in mice and human ALS cases. to the paper |
| wb | Sigma monoclonal anti-actin antibody was used as an internal loading control fro western bloting of p53, WAF1 and MDM2. to the paper |
RocklandRockland ACTB products | |
| wb | Rockland ?-actin antibody was used in western blot in order to study the effect of MDM2-dependent inhibition of p53 on EBV growth transformation of B-cell and infected-cell survival. to the paper |
US BiologicalUS Biological ACTB products | |
| wb | USBiological beta-actin antibody was used in western blot to study Zinc-induced PTEN protein degradation. to the paper |
Santa Cruz BiotechnologySanta Cruz Biotechnology ACTB products | |
| wb | Santa Cruz Biotechnology anti-?-actin antibody was used to perform western blot in order to reveal the role of Id2 in increasing invasion potential of MCF-7 and SKOV-3 cells. to the paper |
| wb | Santa Cruz anti-?-actin antibody was used to perform western blot in order to show that the loss of Faf1 can results in aberrant NF-?B signaling and tumor progression. to the paper |
| wb | Santa Cruz Biotechnology anti-?-actin antibody was used to perform immunoblot analysis in order to illustrate that anthracycline chemotherapy can inhibit the transcription of HIF-1 as well as the mobilization of circulating angiogenic cells in tumor. to the paper |
| wb | Santa Cruz Biotechnology anti-beta-actin antibody was used in western blot to detect beta-actin as a loading control in mouse rhabdomyosarcoma cells and RMS772 cells. to the paper |
| wb | Santa Cruz Biotechnology anti-beta-actin antibody was used in western blot to detect beta-actin as a loading control in 293T cells. to the paper |
| ip, wb | Santa Cruz Biotechnology anti-beta-actin antibody was used in western blot and immunoprecipitation to study the CATERPILLER protein monarch-1 as an antagonist of toll-like receptor-, tumor necrosis factor alpha-, and mycobacterium tuberculosis-induced pro-inflammatory signals. to the paper |
| wb | Santa Cruz anti-beta-actin antibody was used in western blot to study that tumor suppressor SMAR1 mediates Cyclin D1 repression by recruitment of the SIN3/Histone deacetylase 1 complex. to the paper |
| wb | Santa Cruz Biotechnology anti-beta-actin antibody was used in western blot to study the immortalization of bovine lens epithelial cells by human telomerase reverse transcriptase. to the paper |
| wb | Santa Cruz Biotechnology actin antibody was used in western blot to study apoptotic cell death in prostate cancer caused by androgen receptor silencing. to the paper |
| wb | Santa Cruz Biotechnology goat polyclonal anti-actin antibody was used in western blot to detect actin as a loading control in articular chondrocytes. to the paper |
| wb | Santa Cruz Biotechnology anti-beta-actin antibody was used in western blot to detect beta-actin as a loading control in the nuclear protein extracts isolated from the murine cardiomyocytes treated with IL-18. to the paper |
| wb | Santa Cruz Biotechnology polyclonal anti-beta-actin antibody was used in western blot to detect beta-actin as a loading control in HUVECs pretreated with Y-27632 or transfected with C3 transferase. to the paper |
| chip, wb | Santa Cruz Biotechnolog anti-beta-actin monoclonal antibody was used in western blot and ChIP assay to study that KLF11-mediated repression antagonizes Sp1/Sterol-responsive element-binding protein-induced transcriptional activation of caveolin-1 in response to cholesterol signaling. to the paper |
| wb | Santa Cruz Biotechnology anti-beta-actin antibody was used in western blot to detect beta-actin as a loading control in cell extracts from Jurkat-pcDNA or Jurkat-A238L non stimulated or stimulated with PMA plus Ion. to the paper |
| wb | Santa Cruz anti beta-actin antibody was used in western blot to study that Akt/protein kinase B and endothelial nitric Oxide synthase mediate muscular neovascularization induced by tissue kallikrein gene transfer. to the paper |
| wb | Santa Cruz Biotechnology anti-actin antibody was used in western blot to detect actin as a load control in dissociated sympathetic neurons from postnatal day 1 Sprague-Dawley rats. to the paper |
| wb | Santa Cruz Biotechnology anti-actin antibody was used in western blot to detect actin as a load control in cortical neurons, U373 and PC12 cells infected with LacZ or p75NTR recombinant adenovirus. to the paper |
| wb | Santa Cruz Biotechnology goat anti-beta-actin polyclonal antibody was used in western blot to study the osteopontin-dependent CD44v6 expression and cell adhesion in HepG2 cells. to the paper |
| wb | Santa Cruz Biotechnology mouse anti-beta-actin antibody was used in western blot to detect the beta-actin as a control in the T84 human colon epithelial cells, HCA-7 human colon epithelial cells and RIE-1 normal rat intestinal epithelial cells to study the apoptosis of normal and transformed intestinal epithelial cells. to the paper |
| wb | Santa Cruz Biotechnology anti-beta-actin antibody was used in western blot to detect beta-actin as a loading control in mutant and normal B lymphocytes from patients. to the paper |
| wb | Santa Cruz Biotechnology anti-beta-actin antibody was used in western blot to study the differential roles of Smad1 and p38 kinase in regulation of peroxisome proliferator-activating receptor gamma during bone morphogenetic protein 2-induced adipogenesis. to the paper |
| wb | Santa Cruz Biotechnology goat anti-actin antibody was used in western blot to study the induction of extracellular matrix-remodeling genes by the senescence-associated protein APA-1. to the paper |
| wb | Santa Cruz Biotechnology rabbit anti-human actin antibody was used in western blot to detect cytosolic preparations from sIgD cells treated with anti-NGF or control. to the paper |
Articles Reviewed | |
| 1: | Suchitra Basu et al. Gfi-1 represses CDKN2B encoding p15INK4B through interaction with Miz-1. 2009 This publication discusses GFI1 and ZBTB17. Reagent reviews based on this publication are available for Gfi-1 (N-20, Miz-1 (N17, Lipofectamine 2000, and Luciferase assay reagents. |
| 2: | KangAe Lee et al. Anthracycline chemotherapy inhibits HIF-1 transcriptional activity and tumor-induced mobilization of circulating angiogenic cells. 2009 This publication discusses HIF1A. Reagent reviews based on this publication are available for DMEM, RPMI medium 1640, EDTA, FCS, HIF-1, streptomycin, FuGENE-6, Dual Luciferase assay system, TRIzol reagent, ChIP assay kit, Vectastain Elite ABC immunoperoxidase system, DNase, iScript cDNA synthesis system, and iQ SYBR Green Supermix. |
| 3: | Fayçal Guedj et al. Green tea polyphenols rescue of brain defects induced by overexpression of DYRK1A. 2009 |
| 4: | Ivan Topisirovic et al. Stability of eukaryotic translation initiation factor 4E mRNA is regulated by HuR, and this activity is dysregulated in cancer. 2009 This publication discusses MYC, ACTB, TUBA1B, HNRNPC, HNRNPA1, ELAVL1, AUF1, FOS, VEGFA, p53, EIF4E, and cyclin D1. Reagent reviews based on this publication are available for c-myc, Trizol, actin, OneStep RT-PCR kit, tubulin, Sybr Green PCR Master Mix, Fugene 6, hnRNP C1/C2, Lipofectamine 2000, hnRNP A1, HuR siRNA, AUF1 siRNA, c-fos, G418, vascular endothelial growth factor, p53, AUF1, eIF4E, and cyclin D1. |
| 5: | Jeffrey H Hager et al. Genetic ablation of Bcl-x attenuates invasiveness without affecting apoptosis or tumor growth in a mouse model of pancreatic neuroendocrine cancer. 2009 Reagent reviews based on this publication are available for DNase. |
| 6: | Gabriel N Maine et al. COMMD1 expression is controlled by critical residues that determine XIAP binding. 2009 This publication discusses HADH, XIAP, and MURR1. Reagent reviews based on this publication are available for SCHAD, RNeasy, XIAP, Ni-NTA-Agarose beads, and COMMD1. |
| 7: | Zoltán Jakus et al. Critical role of phospholipase Cgamma2 in integrin and Fc receptor-mediated neutrophil functions and the effector phase of autoimmune arthritis. 2009 This publication discusses FGA and NFKBIA. Reagent reviews based on this publication are available for fibrinogen and I??-B. |
| 8: | Eleonora Forte et al. MDM2-dependent inhibition of p53 is required for Epstein-Barr virus B-cell growth transformation and infected-cell survival. 2009 This publication discusses ICAM1, p53, MDM2, CDKN1A, MDM4, and ACTB. Reagent reviews based on this publication are available for CD54, p53, MDM2, p21, MDMX, and beta-actin. |
| 9: | Rene Rodriguez et al. Loss of p53 induces tumorigenesis in p21-deficient mesenchymal stem cells. 2009 This publication discusses TUBB3 and p53. Reagent reviews based on this publication are available for Dulbecco's modified Eagle's medium, trypsin, ABC Vectasain Elite Kit, tubulin III, 3-3??diaminobenzidine tretrachloride, enhanced chemiluminescence detection system, and p53. |
| 10: | Anna J Bowes et al. Valproate attenuates accelerated atherosclerosis in hyperglycemic apoE-deficient mice: evidence in support of a role for endoplasmic reticulum stress and glycogen synthase kinase-3 in lesion development and hepatic steatosis. 2009 Reagent reviews based on this publication are available for SYBR GreenER qPCR SuperMix, Vectastain ABC System, nitrocellulose membranes, and TRIzol reagent. |
| 11: | Shana Marmon et al. Caveolin-1 expression determines the route of neutrophil extravasation through skin microvasculature. 2009 Reagent reviews based on this publication are available for luciferase control siRNA (cat#1022070. |
| 12: | Andreas Winklmeier et al. Loss of full length CtBP1 expression enhances the invasive potential of human melanoma. 2009 This publication discusses CTBP1. Reagent reviews based on this publication are available for fetal calf serum, G418, Superscript II reverse transcriptase, and CtBP1. |
| 13: | Deborah A Altomare et al. Activated TNF-alpha/NF-kappaB signaling via down-regulation of Fas-associated factor 1 in asbestos-induced mesotheliomas from Arf knockout mice. 2009 This publication discusses RELA, LMNB1, and p53. Reagent reviews based on this publication are available for Dual-Luciferase Reporter Assay, protein assay, NF-??B p65, lamin B, and p53. |
| 14: | Giada Monami et al. Proepithelin regulates prostate cancer cell biology by promoting cell growth, migration, and anchorage-independent growth. 2009 This publication discusses ACTB, MAPK1, and GRN. Reagent reviews based on this publication are available for beta-actin, ERK1, enzyme-linked immunosorbent assay, and proepithelin. |
| 15: | Yuanguang Meng et al. Id2 promotes the invasive growth of MCF-7 and SKOV-3 cells by a novel mechanism independent of dimerization to basic helix-loop-helix factors. 2009 This publication discusses ID2 and CDH1. Reagent reviews based on this publication are available for Superscript III RNase H- reverse transcriptase, Dulbecco's modified Eagle's medium, RPMI1640, Matrigel, Dual-Luciferase Reporter Assay System, G418, Lipofectamine 2000, Id2-specific siRNA, Id2, and E-cadherin. |
| 16: | Caterina Nardella et al. Aberrant Rheb-mediated mTORC1 activation and Pten haploinsufficiency are cooperative oncogenic events. 2008 This publication discusses RHEB. Reagent reviews based on this publication are available for transfection reagent Lipofectamine RNAiMax, Complete protease inhibitor tablet, Human Rheb cDNA, TRIzol, and RNeasy Mini Kit. |
| 17: | Fabián Arenas et al. Combination of ursodeoxycholic acid and glucocorticoids upregulates the AE2 alternate promoter in human liver cells. 2008 This publication discusses HNF1B, p300, glucocorticoid receptor, and HNF1A. Reagent reviews based on this publication are available for RPMI 1640, HNF1β, ECL reagent, dexamethasone, Complete Protease Inhibitor, TRI Reagent, p300, Dual-Luciferase Reporter Assay System, Lipofectamine 2000, QIAamp DNA Mini Kit, GR, and HNF1α. |
| 18: | Young Kwang Chae et al. Human AQP5 plays a role in the progression of chronic myelogenous leukemia (CML). 2008 This publication discusses BCR, ABL1, ACTB, and AQP5. Reagent reviews based on this publication are available for leupeptin, Bcr, c-Abl, actin, RPMI medium, Opti-MEM I reduced serum medium, fetal bovine serum, TRIzol, probe for AQP5, aprotinin, and AQP5. |
| 19: | Yanlin Yu et al. The homeoprotein six1 transcriptionally activates multiple protumorigenic genes but requires ezrin to promote metastasis. 2006 |
| 20: | Noriyuki Uemura et al. TAK1 is a component of the Epstein-Barr virus LMP1 complex and is essential for activation of JNK but not of NF-kappaB. 2006 This publication discusses MAPK8, RELA, and TRAF2. Reagent reviews based on this publication are available for JNK, p65, JNK1, and TRAF2. |
| 21: | Jie Zhao et al. IRF-8/interferon (IFN) consensus sequence-binding protein is involved in Toll-like receptor (TLR) signaling and contributes to the cross-talk between TLR and IFN-gamma signaling pathways. 2006 This publication discusses MAPK1, MAPK8, IRF8, TRAF6, and MYD88. Reagent reviews based on this publication are available for ERK, JNK, IRF-8, TRAF6, and MyD88. |
| 22: | Hui Wang et al. Overexpression of ribosomal protein L15 is associated with cell proliferation in gastric cancer. 2006 This publication discusses ribosomal protein L15, cyclin D1, and CCNB1. Reagent reviews based on this publication are available for RPL15, Cyclin D1, and Cyclin B1. |
| 23: | Bryan D Griffin et al. Persistent interleukin-1beta signaling causes long term activation of NFkappaB in a promoter-specific manner in human glial cells. 2006 This publication discusses RELA, NFKBIB, IKBKB, and NFKBIA. Reagent reviews based on this publication are available for p65, IkappaBbeta, IKKbeta, and IkappaBalpha. |
| 24: | Soon-Young Choi et al. Activation of Bak and Bax through c-abl-protein kinase Cdelta-p38 MAPK signaling in response to ionizing radiation in human non-small cell lung cancer cells. 2006 This publication discusses PRKCB, CASP3, PRKCE, PARP1, MAPK1, cytochrome c, MAPK14, ACTB, MAPK8, BAK1, HSPD1, ABL1, PRKCD, and PRKCA. Reagent reviews based on this publication are available for PKC beta 1, caspase 3, PKC epsilon, PARP, MAPK, cytochrome c, p38 MAPK, beta-Actin, JNK, Bak, HSP60, c-Abl, PKC delta, and PKC alpha. |
| 25: | Annett Hahn-Windgassen et al. Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity. 2005 This publication discusses ACACA, EIF4EBP1, RPS6KB1, TSC2, PRKAA1, RPS6, and ACTB. Reagent reviews based on this publication are available for phospho-ACC-S79, phospho-4E-BP-S65, S6K1, phospho-TSC2-T1462, AMPK, phospho-S6-S235/236, TSC2, and beta-actin. |
| 26: | Christopher C Valley et al. Differential regulation of estrogen-inducible proteolysis and transcription by the estrogen receptor alpha N terminus. 2005 This publication discusses ACTB, CDK7, SRC, p300, MDM2, UBE3A, PSMC5, and POLR2A. Reagent reviews based on this publication are available for actin, cyclin-dependent kinase 7, SRC1, p300, MDM2, E6-AP, TRIP1/Rpt6, and p-Pol II. |
| 27: | Tomoya S Kitajima et al. Human Bub1 defines the persistent cohesion site along the mitotic chromosome by affecting Shugoshin localization. 2005 |
| 28: | Andrew V Samuelson et al. p400 is required for E1A to promote apoptosis. 2005 This publication discusses EP400, CREBBP, RB1, p53, and CDKN2A. Reagent reviews based on this publication are available for E1A, CBP, Rb, p53, p19ARF, and ARF. |
| 29: | Shravanti Rampalli et al. Tumor suppressor SMAR1 mediates cyclin D1 repression by recruitment of the SIN3/histone deacetylase 1 complex. 2005 This publication discusses p107, cyclin D1, NOLC1, CCND3, SIN3A, CCND2, SIN3B, CDK4, p27, RB1, STAT5A, E2F1, and HDAC1. Reagent reviews based on this publication are available for p107, cyclin D1, p130, cyclin D3, Sin3A, cyclin D2, Sin3B, CDK4, p27, pRb, pStat5, E2F1, and HDAC1. |
| 30: | Xinbo Liao et al. Small-interfering RNA-induced androgen receptor silencing leads to apoptotic cell death in prostate cancer. 2005 This publication discusses BAX, BAK1, ACTB, CASP3, CASP6, CYC1, XIAP, DFFA, PARP1, Bcl 2, and BCL2L1. Reagent reviews based on this publication are available for Bax, Bak, actin, caspase-3, caspase-6, cytochrome c, XIAP, DFF45, poly(ADP-ribose) polymerase, Bcl-2, and Bcl-xL. |
| 31: | Kabsun Kim et al. Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis. 2005 |
| 32: | Kohsuke Kanekura et al. A Rac1/phosphatidylinositol 3-kinase/Akt3 anti-apoptotic pathway, triggered by AlsinLF, the product of the ALS2 gene, antagonizes Cu/Zn-superoxide dismutase (SOD1) mutant-induced motoneuronal cell death. 2005 This publication discusses Cu Zn superoxide dismutase, RAC1, CDC42, RHOA, ACTB, APP, PSEN1, PSEN2, and AKT1. Reagent reviews based on this publication are available for SOD1, Rac1, Cdc42, RhoA, actin, APP, PS1, PS2, and phosphorylated-Akt (Ser-473). |
| 33: | Sheng Cao et al. KLF11-mediated repression antagonizes Sp1/sterol-responsive element-binding protein-induced transcriptional activation of caveolin-1 in response to cholesterol signaling. 2005 This publication discusses CAV1, SREBF1, SP1, and KLF11. Reagent reviews based on this publication are available for Caveolin-1, SREBP, Sp1, and KLF11. |
| 34: | Nikos Tapinos et al. Insights into regulation of human Schwann cell proliferation by Erk1/2 via a MEK-independent and p56Lck-dependent pathway from leprosy bacilli. 2005 This publication discusses CAV1, MAPK1, MAP2K1, ELK1, PRKCA, PRKD1, PRKCZ, LCK, PRKCE, cyclin D1, and CDKN1A. Reagent reviews based on this publication are available for caveolin-1, phospho-Erk1/2, phospho-MEK1/2, phospho-Elk1, phospho-PKCa /b II, phospho-PKD/PKCm, phospho-PKCz /l, phospho-Lck, phospho-PKCe, cyclin D1, and p21. |
| 35: | Zsuzsanna Orbán-Németh et al. Microtubule-associated protein 1S, a short and ubiquitously expressed member of the microtubule-associated protein 1 family. 2005 This publication discusses TUBA4A. Reagent reviews based on this publication are available for tubulin. |
| 36: | Laura V Gonzalez Bosc et al. Nuclear factor of activated T cells and serum response factor cooperatively regulate the activity of an alpha-actin intronic enhancer. 2005 This publication discusses NFATC3 and SRF. Reagent reviews based on this publication are available for NFATc3 and SRF. |
| 37: | Manabu Fujita et al. Overexpression of beta1-chain-containing laminins in capillary basement membranes of human breast cancer and its metastases. 2005 This publication discusses KRT8, KRT18, LAMA5, LAMB2, LAMC2, ACTB, and LAMB1. Reagent reviews based on this publication are available for cytokeratin-8, cytokeratin-18, Laminin alpha5 chain, Laminin beta2 chain, Laminin gamma2 chain, beta-actin, and Laminin beta1 chain. |
| 38: | Juan Wang et al. Human telomerase reverse transcriptase immortalizes bovine lens epithelial cells and suppresses differentiation through regulation of the ERK signaling pathway. 2005 This publication discusses MAPK1, MAP2K1, PRKACA, CRYBA4, BFSP1, and TERT. Reagent reviews based on this publication are available for ERK, p-ERK, MEK, PKA, beta-crystallin, filensin, and hTERT. |
| 39: | Karim Kaabeche et al. Cbl-mediated ubiquitination of alpha5 integrin subunit mediates fibronectin-dependent osteoblast detachment and apoptosis induced by FGFR2 activation. 2005 This publication discusses FGFR2, ITGA5, CBL, ITGAV, ITGB1, ACTB, UBA52, and BAX. Reagent reviews based on this publication are available for FGFR2, alpha-5 integrin, Cbl, alpha-V integrin, ß1, ß-actin, ubiquitin, and Bax. |
| 40: | Sang-Gu Hwang et al. Regulation of beta-catenin signaling and maintenance of chondrocyte differentiation by ubiquitin-independent proteasomal degradation of alpha-catenin. 2005 This publication discusses CTNNA1, COL2A1, CTNND1, JUP, CDH2, ACTB, and CTNNB1. Reagent reviews based on this publication are available for alpha-catenin, Type II collagen, pp120, gamma-catenin, N-cadherin, actin, and beta-catenin. |
| 41: | Andrew B West et al. Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. 2005 This publication discusses VDAC1 and PRKG1. Reagent reviews based on this publication are available for porin and PGK. |
| 42: | Kiven Erique Lukong et al. Tyrosine phosphorylation of sam68 by breast tumor kinase regulates intranuclear localization and cell cycle progression. 2005 This publication discusses PTK6. Reagent reviews based on this publication are available for BRK. |
| 43: | Bysani Chandrasekar et al. Interleukin-18 is a pro-hypertrophic cytokine that acts through a phosphatidylinositol 3-kinase-phosphoinositide-dependent kinase-1-Akt-GATA4 signaling pathway in cardiomyocytes. 2005 |
| 44: | An-Sheng Zhang et al. Interaction of hemojuvelin with neogenin results in iron accumulation in human embryonic kidney 293 cells. 2005 This publication discusses FTL, NEO1, and DCC. Reagent reviews based on this publication are available for ferritin, neogenin, and DCC. |
| 45: | Manish K Tripathi et al. Regulation of BRCA2 gene expression by the SLUG repressor protein in human breast cells. 2005 This publication discusses CTBP1, HDAC1, and H3F3B. Reagent reviews based on this publication are available for CtBP-1, HDAC-1, and acetyl histone H3. |
| 46: | Kristi L Williams et al. The CATERPILLER protein monarch-1 is an antagonist of toll-like receptor-, tumor necrosis factor alpha-, and Mycobacterium tuberculosis-induced pro-inflammatory signals. 2005 This publication discusses IRAK1. Reagent reviews based on this publication are available for IRAK-1. |
| 47: | Jing-Xu Zhu et al. Decorin evokes protracted internalization and degradation of the epidermal growth factor receptor via caveolar endocytosis. 2005 This publication discusses decorin, CAV1, EEA1, CD63, RAB11A, GOLGA4, and EGFR. Reagent reviews based on this publication are available for decorin, caveolin-1, early endosome antigen 1 (EEA1), CD63, Rab11, p230 trans-Golgi, and EGFR. |
| 48: | Bernard Dublet et al. Cleavage of p21/WAF1/CIP1 by proteinase 3 modulates differentiation of a monocytic cell line. Molecular analysis of the cleavage site. 2005 This publication discusses CDKN1A. Reagent reviews based on this publication are available for p21. |
| 49: | N A C S Wong et al. CDX1 is an important molecular mediator of Barrett's metaplasia. 2005 This publication discusses CDX2, NFKB1, and MAPK1. Reagent reviews based on this publication are available for CDX2, NF-kappa B, and ERK. |
| 50: | Sophie Bonnal et al. Heterogeneous nuclear ribonucleoprotein A1 is a novel internal ribosome entry site trans-acting factor that modulates alternative initiation of translation of the fibroblast growth factor 2 mRNA. 2005 This publication discusses FGF2. Reagent reviews based on this publication are available for FGF-2. |
| 51: | Lakita G Cavin et al. Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas. 2005 |
| 52: | Jianmin Zhang et al. Cdc42 and RhoB activation are required for mannose receptor-mediated phagocytosis by human alveolar macrophages. 2005 This publication discusses CDC42, RAC1, RHOB, RHOA, PAK1, and TUBB. Reagent reviews based on this publication are available for Cdc42, Rac1, RhoB, RhoA, PAK1, and beta-tubulin. |
| 53: | Jing Li et al. Myristoylated alanine-rich C kinase substrate-mediated neurotensin release via protein kinase C-delta downstream of the Rho/ROK pathway. 2005 This publication discusses ROCK1, MARCKS, and PRKCD. Reagent reviews based on this publication are available for ROK alpha, MARCKS, and PKC-delta. |
| 54: | Alessandra Alberghini et al. Loss of the von Hippel Lindau tumor suppressor disrupts iron homeostasis in renal carcinoma cells. 2005 This publication discusses VHL, transferrin receptor, and HIF1A. Reagent reviews based on this publication are available for VHL, TfR, and HIF-1alpha. |
| 55: | Brian A Pierchala et al. Nerve growth factor promotes the survival of sympathetic neurons through the cooperative function of the protein kinase C and phosphatidylinositol 3-kinase pathways. 2004 |
| 56: | Stephan Kiessling et al. Functional expression of the interleukin-11 receptor alpha-chain and evidence of antiapoptotic effects in human colonic epithelial cells. 2004 This publication discusses NFKBIA, IL11RA, IL6ST, EP4, JAK1, STAT3, ACTB, and AKT1. Reagent reviews based on this publication are available for IkappaBalpha, IL-11Ralpha, gp130, EP-4, Jak1, phosphotyrosine Jak1, STAT3, phosphotyrosine STAT3, beta-actin, and Akt. |
| 57: | Jinhu Yin et al. RECQL4, mutated in the Rothmund-Thomson and RAPADILINO syndromes, interacts with ubiquitin ligases UBR1 and UBR2 of the N-end rule pathway. 2004 This publication discusses CTNNB1. Reagent reviews based on this publication are available for ß-catenin. |
| 58: | Michael J Piatelli et al. Phosphatidylinositol 3-kinase-dependent mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 and NF-kappa B signaling pathways are required for B cell antigen receptor-mediated cyclin D2 induction in mature B cells. 2004 This publication discusses RB1. Reagent reviews based on this publication are available for pRb. |
| 59: | Soheil Naderi et al. cAMP-induced degradation of cyclin D3 through association with GSK-3beta. 2004 This publication discusses AKAP95, CDK4, CDK6, CCND3, and GSK3B. Reagent reviews based on this publication are available for AKAP95, CDK4, CDK6, cyclin D3, and GSK-3 beta. |
| 60: | Irene M Ward et al. UV-induced ataxia-telangiectasia-mutated and Rad3-related (ATR) activation requires replication stress. 2004 This publication discusses CHEK1 and ATR. Reagent reviews based on this publication are available for Chk1 and ATR. |
| 61: | Costanza Emanueli et al. Akt/protein kinase B and endothelial nitric oxide synthase mediate muscular neovascularization induced by tissue kallikrein gene transfer. 2004 |
| 62: | Silvestre Vicent et al. Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients. 2004 This publication discusses DUSP1, MAPK1, MAPK14, and MAPK8. Reagent reviews based on this publication are available for CL100/MKP-1, ERK, p38, and JNK. |
| 63: | Ajoy K Samanta et al. Overexpression of MEKK3 confers resistance to apoptosis through activation of NFkappaB. 2004 This publication discusses MEKK3, PARP1, CASP3, CASP8, XIAP, AKT1, and ACTB. Reagent reviews based on this publication are available for MEKK3, PARP, caspase 3, caspase 8, xIAP, pAkt, and actin. |
| 64: | Lynne Cassimeris et al. TOGp, the human homolog of XMAP215/Dis1, is required for centrosome integrity, spindle pole organization, and bipolar spindle assembly. 2004 This publication discusses TUBG1 and PCNT. Reagent reviews based on this publication are available for gamma-tubulin and pericentrin. |
| 65: | Renaud Dentin et al. Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression. 2004 This publication discusses SREBF1. Reagent reviews based on this publication are available for SREBP-1. |
| 66: | Aitor G Granja et al. The viral protein A238L inhibits cyclooxygenase-2 expression through a nuclear factor of activated T cell-dependent transactivation pathway. 2004 This publication discusses PTGS2 and NFATC2. Reagent reviews based on this publication are available for COX-2 and NFAT. |
| 67: | Khandaker N Anwar et al. RhoA/Rho-associated kinase pathway selectively regulates thrombin-induced intercellular adhesion molecule-1 expression in endothelial cells via activation of I kappa B kinase beta and phosphorylation of RelA/p65. 2004 This publication discusses ICAM1, IKBKB, NFKBIA, and RELA. Reagent reviews based on this publication are available for ICAM-1, IKKbeta, IkappaBalpha, and RelA/p65. |
| 68: | Alberto Ballestrero et al. Tumor necrosis factor-related apoptosis-inducing ligand cooperates with anticancer drugs to overcome chemoresistance in antiapoptotic Bcl-2 family members expressing jurkat cells. 2004 This publication discusses CASP3, CASP8, BCL2L1, and ACTB. Reagent reviews based on this publication are available for caspase-3, caspase-8, Bcl-xL, and beta-actin. |
| 69: | Eisuke Itakura et al. Amino-terminal domain of ATRIP contributes to intranuclear relocation of the ATR-ATRIP complex following DNA damage. 2004 This publication discusses ATR, RPA1, and RPA2. Reagent reviews based on this publication are available for ATR, RPA p70, and RPA p34. |
| 70: | Md Ruhul Abid et al. Vascular endothelial growth factor-mediated induction of manganese superoxide dismutase occurs through redox-dependent regulation of forkhead and IkappaB/NF-kappaB. 2004 This publication discusses NFKBIA, RELA, FOXO1, ACTB, MAPK3, MAPK1, MAPK8, and CREB. Reagent reviews based on this publication are available for IkappaB, p65 NF-kappaB, FKHR, beta-actin, Erk1, Erk2, JNK, and CREB. |
| 71: | Hiroshi Nishihara et al. Inhibition of apoptosis in normal and transformed intestinal epithelial cells by cAMP through induction of inhibitor of apoptosis protein (IAP)-2. 2003 This publication discusses FAS, BIRC3, BIRC2, PARP1, CREB, NFKBIA, and ACTB. Reagent reviews based on this publication are available for Fas, (c-IAP)-2, c-IAP1, poly(ADP-ribose) polymerase (PARP), CREB, IkappaBalpha, and beta-actin. |
| 72: | Pierre-François Cartron et al. Nonredundant role of Bax and Bak in Bid-mediated apoptosis. 2003 This publication discusses BAX, glial fibrillary acidic protein, ACTB, BCL2L1, BID, BAK1, and cytochrome c. Reagent reviews based on this publication are available for Bax, GFAP, actin, Bcl-XL, Bid, Bak, and cytochrome c. |
| 73: | Weidong Wu et al. Zinc-induced PTEN protein degradation through the proteasome pathway in human airway epithelial cells. 2003 This publication discusses PTEN, UBA52, and ACTB. Reagent reviews based on this publication are available for PTEN, ubiquitin, and beta-actin. |
| 74: | Xiaoyan Jiang et al. Evidence for a positive role of SHIP in the BCR-ABL-mediated transformation of primitive murine hematopoietic cells and in human chronic myeloid leukemia. 2003 This publication discusses STAT5A, INPP5D, and ACTB. Reagent reviews based on this publication are available for STAT5A, SHIP, and beta-actin. |
| 75: | Chengjiang Gao et al. Osteopontin-dependent CD44v6 expression and cell adhesion in HepG2 cells. 2003 This publication discusses CD44. Reagent reviews based on this publication are available for CD44v6. |
| 76: | Asha L Bhakar et al. Apoptosis induced by p75NTR overexpression requires Jun kinase-dependent phosphorylation of Bad. 2003 This publication discusses CASP9, CASP6, CASP3, PARP1, MAPK8, JUN, ACTB, and BAD. Reagent reviews based on this publication are available for caspase-9, caspase-6, caspase-3, PARP, JNK1, JNK, c-Jun, actin, and Bad. |
| 77: | Audrey Robinson-White et al. Protein kinase-A activity in PRKAR1A-mutant cells, and regulation of mitogen-activated protein kinases ERK1/2. 2003 This publication discusses MAPK1, CD23, and ACTB. Reagent reviews based on this publication are available for ERK2, CD23, and beta-actin. |
| 78: | Fuminori Umenishi et al. Hypertonicity-induced aquaporin-1 (AQP1) expression is mediated by the activation of MAPK pathways and hypertonicity-responsive element in the AQP1 gene. 2003 This publication discusses MAPK1, MAPK14, MAPK8, MAP2K1, MAP2K2, MAP2K3, MAP2K6, and MAP2K4. Reagent reviews based on this publication are available for ERK, p38 kinase, JNK, MEK1, MEK2, MAPK kinase 3, MAPK kinase 6, and MAPK kinase 4. |
| 79: | Alison McDowall et al. A novel form of integrin dysfunction involving beta1, beta2, and beta3 integrins. 2003 This publication discusses ezrin, PRKCQ, ITGAL, ACTB, integrin linked kinase, ITGA2B, FYB, ITGB3, RAP1A, ITGB1, RHOA, ITGB2, RAC1, ITGA4, RAC2, FLNA, CDC42, TLN1, PRKCA, PRKCB, vinculin, and PRKCD. Reagent reviews based on this publication are available for ezrin, PKC-theta, integrin alpha L, actin, ILK, integrin alpha IIb, SLAP-130, integrin beta 3, Rap-1, integrin beta 1, RhoA, integrin beta 2, Rac-1, integrin alpha 4, Rac-2, filamin, Cdc42, talin, PKC-alpha, PKC-beta, vinculin, and PKC-delta. |
| 80: | Gary S Goldberg et al. Src phosphorylates Cas on tyrosine 253 to promote migration of transformed cells. 2003 This publication discusses BCAR1, SRC, MAPK1, ACTB, and CRK. Reagent reviews based on this publication are available for P130 Cas, pp60 Src, P42 MAPK, beta-actin, and Crk. |
| 81: | Maoxiang Li et al. The phosphatase MKP1 is a transcriptional target of p53 involved in cell cycle regulation. 2003 This publication discusses p53, DUSP1, and CDKN1A. Reagent reviews based on this publication are available for p53, MKP1, and p21WAF1. |
| 82: | Atsushi Saito et al. Overexpression of copper/zinc superoxide dismutase in transgenic mice protects against neuronal cell death after transient focal ischemia by blocking activation of the Bad cell death signaling pathway. 2003 This publication discusses BAD, BCL2L1, 14 3 3, COX4I1, and HSPD1. Reagent reviews based on this publication are available for Bad, Bcl-xL, 14-3-3, cytochrome oxidase IV, and HSP60. |
| 83: | Jonathan P Aumais et al. Role for NudC, a dynein-associated nuclear movement protein, in mitosis and cytokinesis. 2003 This publication discusses PLK1 and TUBB1. Reagent reviews based on this publication are available for Plk1 and beta-tubulin. |
| 84: | Kenji Hata et al. Differential roles of Smad1 and p38 kinase in regulation of peroxisome proliferator-activating receptor gamma during bone morphogenetic protein 2-induced adipogenesis. 2003 This publication discusses PPARG, ACTB, and MAPK14. Reagent reviews based on this publication are available for PPAR gamma, beta-actin, and p38 kinase. |
| 85: | Anne M Comi et al. Increased fibronectin expression in sturge-weber syndrome fibroblasts and brain tissue. 2003 This publication discusses FN1 and TNC. Reagent reviews based on this publication are available for fibronectin and hexabrachion. |
| 86: | Philippe Garnier et al. Ischemic preconditioning by caspase cleavage of poly(ADP-ribose) polymerase-1. 2003 |
| 87: | Roberto R Rosato et al. Simultaneous activation of the intrinsic and extrinsic pathways by histone deacetylase (HDAC) inhibitors and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) synergistically induces mitochondrial damage and apoptosis in human leukemia cells. 2003 This publication discusses CASP8, CDKN1A, AIFM1, BCL2L1, cytochrome c, XIAP, cyclin D1, BAX, CCNA2, BAK1, CCNE1, RB1, MCL1, ACTB, BID, PARP1, and CASP3. Reagent reviews based on this publication are available for caspase-8, p21WAF1/CIP1, apoptosis-inducing factor (AIF), Bcl-XL, cytochrome c, XIAP, cyclin D1, Bax, cyclin A, Bak, cyclin E, Rb, Mcl-1, actin, Bid, PARP, and procaspase-3. |
| 88: | Tadashi Yoshii et al. Galectin-3 phosphorylation is required for its anti-apoptotic function and cell cycle arrest. 2002 This publication discusses galectin 3, CCNA2, cyclin D1, CCNE1, CDKN1A, CDKN1B, and PARP1. Reagent reviews based on this publication are available for Gal-3, cyclin A, cyclin D1, cyclin E, p21WAF1/CIP1, p27KIP1, and PARP. |
| 89: | Jennifer A Benanti et al. Induction of extracellular matrix-remodeling genes by the senescence-associated protein APA-1. 2002 This publication discusses ARPC5, CDKN1A, p53, and CDKN2A. Reagent reviews based on this publication are available for p16, p21, p53, and p14ARF. |
| 90: | Denise C Hocking et al. A cryptic fragment from fibronectin's III1 module localizes to lipid rafts and stimulates cell growth and contractility. 2002 |
| 91: | Eun Ran Suh et al. DNA methylation down-regulates CDX1 gene expression in colorectal cancer cell lines. 2002 |
| 92: | M Torcia et al. Nerve growth factor inhibits apoptosis in memory B lymphocytes via inactivation of p38 MAPK, prevention of Bcl-2 phosphorylation, and cytochrome c release. 2001 This publication discusses MAPK8, HSPD1, ACTB, PARP1, cytochrome c, and MAPK14. Reagent reviews based on this publication are available for JNK, hsp60, actin, PARP, cytochrome c, and p38 MAPK. |
| 93: | C Guégan et al. Recruitment of the mitochondrial-dependent apoptotic pathway in amyotrophic lateral sclerosis. 2001 This publication discusses CYC1. Reagent reviews based on this publication are available for cytochrome c. |
| 94: | S Nakamura et al. Multiple lysine mutations in the C-terminal domain of p53 interfere with MDM2-dependent protein degradation and ubiquitination. 2000 This publication discusses CDKN1A, UBA52, MDM2, and p53. Reagent reviews based on this publication are available for WAF1, ubiquitin, MDM2, and p53. |